Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

NOVO NORDISK : Goldman Sachs reiterates its Buy rating

06/07/2021 | 09:50am EDT

In a research note published by Keyur Parekh, Goldman Sachs advises its customers to buy the stock. The target price is unchanged at DKK 517.


© MarketScreener with dpa-AFX Analyser 2021
All news about NOVO NORDISK A/S
07/19NOVO NORDISK A/S : – Share repurchase programme
AQ
07/19NOVO NORDISK : Barclays maintains a Buy rating
MD
07/13PROTHENA : Oppenheimer Adjusts Prothena PT to $76 From $54, Maintains Outperform..
MT
07/12NOVO NORDISK A/S : to buy Prothena's heart drug in deal worth up to $1.2 billion
RE
07/12PROTHENA : Sells ATTR Amyloidosis Program to Novo Nordisk
MT
07/12NOVO NORDISK A/S : To Acquire Rights To Prothena's ATTR Amyloidosis Program
MT
07/12NOVO NORDISK : Jefferies gives a Sell rating
MD
07/09President Biden's Competition Order to Crack Down on Antitrust Practices by B..
MT
07/07NOVO NORDISK A/S : Parent Acquires Minority Stake in Availity
MT
07/07SYNACT PHARMA : Appoints New Chief Medical Officer
MT
More news
Financials
Sales 2021 133 B 21 099 M 21 099 M
Net income 2021 44 318 M 7 017 M 7 017 M
Net cash 2021 6 391 M 1 012 M 1 012 M
P/E ratio 2021 29,7x
Yield 2021 1,70%
Capitalization 1 309 B 207 B 207 B
EV / Sales 2021 9,78x
EV / Sales 2022 8,97x
Nbr of Employees 45 157
Free-Float 69,8%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Last Close Price 570,90 DKK
Average target price 485,37 DKK
Spread / Average Target -15,0%
EPS Revisions
Managers and Directors
Lars Fruergaard Jørgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Henrik Ehlers Wulff Executive VP & Head-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
NOVO NORDISK A/S33.81%188 446
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246